Kura Oncology Inc
(NASDAQ:KURA)
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
top performing KURA trades
![Chris Jacobs headshot](https://clerk.house.gov/content/assets/img/members/J000020.jpg)
Chris Jacobs
House (R-NY)
50.00%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Kura Oncology trades made by congress members.
![]() Chris JacobsHouse (R-NY) | $1K - $15K | stock | Purchase | Jan 20, 2023 | Dec 12, 2022 | House |